You are here

Program News and Releases

Vitamin C May Help Treat Certain Blood Cancers

Research from Iannis Aifantis and colleagues at NYU School of Medicine finds vitamin C may work as a therapy for some leukemias and myelodysplastic syndromes by activating TET2.

read more

NYSTEM Consortium Creates Spinoff Company

A NYSTEM funded consortium based at Roswell Park Cancer Institute launched a new biotechnology company to target cancer

read more

Parkin mutations cause changes in electrophysiological properties of neurons

Jian Feng’s group identifies a pathophysiological change in neurons derived from Parkinson’s patients harboring parkin mutations

read more

NYSTEM Awardee Launches Biotech Company

Regenerative medicine company receives venture capital funding for Parkinson’s research

read more

Patient Cells Shed Light On Developmental Mechanisms Underlying Schizophrenia

A new research collaboration from scientists at the University at Buffalo and the Icahn School of Medicine at Mount Sinai identifies a role for Integrative Nuclear FGFR1 Signaling in schizophrenia

read more

Toward Personalizing Treatments of Gliomas

Testing TGF-β inhibition as a radiosensitizer in tumor explants points toward a future of personalized therapies

read more

A Developmental Program for Cell Cannibalism

Research from Jeremy Nance identifies cell cannibalism during development of C. elegans

read more

Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumors into Chemoresistant Cancer Stem Cells

Vascular niche of tumor-associated vascular endothelial cells (TECs) can enable cancer stem cell aggressiveness.

read more

NYSTEM Releases Second Strategic Plan

ESSCB releases second Strategic Plan reviewing NYSTEM's accomplishments and setting forth objectives for the next phase of the program: "The New York State Stem Cell Science (NYSTEM) Program: A Report on Progress and a Vision for the Future."

read more

International Collaboration Produces Haploid Human Embryonic Stem Cells

An international collaboration between researchers in New York and Israel produces haploid human embryonic stem cells capable of normal differentiation.

read more


Subscribe to News Feed